• 1
    Palese P. Influenza: old and new threats. Nat Med2004; 10(Suppl 12):S82S87.
  • 2
    Palese P, Shaw ML. “Orthomyxoviridae: the viruses and their replication”. In: Knipe DM, Howley PM, Griffin DE et al. (eds) Fields Virol2007:16471689. Philadelphia: Wolters Kluwer; Lippincott Williams & Wilkins.
  • 3
    Palese P, Wang TT. H5N1 influenza viruses: facts, not fear. Proc Natl Acad Sci U S A. 2012 Feb 14; 109:22113.
  • 4
    Wainright PO, Perdue ML, Brugh M, Beard CW. Amantadine resistance among hemagglutinin subtype 5 strains of avian influenza virus. Avian Dis1991; 35:3139.
  • 5
    Bahlky H. Avian influenza: the tip of the iceberg. Ann Thorac Med2009; 3:154157.
  • 6
    Suzuki Y. The highly pathogenic avian influenza H5N1-initial molecular signals for the next influenza pandemic. Chang Gung Med J2009; 32:258263.
  • 7
    Cannell JJ, Zasloff M, Giovannucci E. On the epidemiology of influenza. Virology J2008; 5:29.
  • 8
    Hayden F. Developing new antiviral agents for influenza treatment: what does the future hold?Clin Infec Dis2009; 48:S3S13.
  • 9
    Jefferson T, Di Pietrantonj C, Debalini MG, Rivetti A, Demicheli V. Inactivated influenza vaccines: methods, policies, and politics. J Clin Epidemiol2009; 62:677686.
  • 10
    Lackenby A, Thompson CI, Democratis J. The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infec Dis2008; 21:626638.
  • 11
    Linhares RE, Wigg MD, Lagrota MH, Nozawa CM. The in vitro antiviral activity of isoprinosine on simian rotavirus (SA-11). Braz J Med Biol Res1989; 22:10951103.
  • 12
    Cheng PKC, Leung TWC, Ho ECM et al. Oseltamivir- and amantadine-resistant influenza viruses A (H1N1). Emerg Infec Dis2009; 15:966968.
  • 13
    Kitching A, Roche A, Balasegaram S, Heathcock R, Maguire H. Oseltamivir adherence and side effects among children in three London schools affected by influenza A (H1N1) v, May 2009 an internet-based cross-sectional survey. Eurosurveillance2009; 14:14.
  • 14
    Dutkowski R. Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. J Antimicrob Chemother2010; 65(Suppl 2):ii11ii24.
  • 15
    Kretzing S, Abraham G. Dose-dependent emetic effects of the Amaryllidaceous alkaloid lycorine in beagle dogs. Toxicon2011; 57:117124.
  • 16
    Dewick PM. The biosynthesis of C5-C25 terpenoid compounds. Nat Prod Rep2002; 19:181222.
  • 17
    Jin Z. Amaryllidaceae and Sceletium alkaloids. Nat Prod Rep2003; 20:606614.
  • 18
    Jin Z. Amaryllidaceous and Sceletium alkaloids. Nat Prod Rep2007; 24:886905.
  • 19
    Zupkó I, Réthy B, Hohmann J, Molnár J, Ocsovszki I, Falkay G. Antitumor activity of alkaloids derived from Amaryllidaceae species. In Vivo2009; 23:4148.
  • 20
    Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull1996; 19:15181520.
  • 21
    DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol1978; 235:E97E102.
  • 22
    Li C, Hatta M, Watanabe S, Neumann G, Kawaoka Y. Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses. J Virol2008; 82:1188011888.
  • 23
    Leung BW, Chen H, Brownlee GG. Correlation between polymerase activity and pathogenicity in two duck H5N1 influenza viruses suggests that the polymerase contributes to pathogenicity. Virology2010; 401:96106.
  • 24
    Liu SW, Li RM, Zhang R et al . CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry. Eur J Pharmacol2011; 660:460467.
  • 25
    Zheng B, Mittal SK, Graham FL, Prevec L. The E1 sequence of bovine adenovirus type 3 and complementation of human adenovirus type 5 E1A function in bovine cells. Virus Res1994; 31:163186.
  • 26
    Kwon H-J, Kim H-H, Yoon SY. In Vitro inhibitory activity of Alpinia katsumadai extracts against influenza virus infection and hemagglutination. Virology J2010; 7:307.
  • 27
    Shin Y-K, Liu Q, Tikoo S-K, Babiuk L-A, Zhou Y. Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. J Gen Virol2007; 88:942950.
  • 28
    Wu M-S, Yen HR, Chang CW, et al. Mechanism of action of the suppression of influenza virus replication by Ko-Ken Tang through inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway and viral RNP nuclear export. J Ethnopharmacol2011; 134:614623.
  • 29
    Li C, Liu VW, Chan DW, Yao KM, Ngan HY. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells. Int J Gynecol Cancer2012; 22:1522.
  • 30
    Lamb J. The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer2007; 7:5460.
  • 31
    Evidente A, Rosaria cicala M, Giudicanni I, Randazzo G, Riccio R. 1H and 13C NMR analysis if lycorine and α-dihydrolycorine. Phytochemistry1983; 22:581584.
  • 32
    Viladomat F, Giovanna R, Bastida J. Alkaloids from Brunsvigia orientalis. Phytochemistry1996; 43:13791384.
  • 33
    August W. Frahm, Ahmed A. Ali, Mahmoud A. Ramadan. 13C nuclear magnetic resonance spectra of Amaryllidaceae alkaloids. Magn Reson Chem1985; 23:804808.
  • 34
    Masaru KiHRA, Konishi K, Lai XU, Shigeru Kobayashi. Alkaloidal constituents of flowers of lycoris radiate HERB (Amaryllidaceae). Chem Pharm Bull1991; 39:18481853.
  • 35
    Evidente A. Identification of 1 1-Hydroxwittatine in Sternbergialutea lutea. J Nat Prod1986; 49:168169.
  • 36
    Evidente A, Andolfi A, Shawky E. (-)-Amarbellisine, a lycorine-type alkaloid from Amaryllis belladonna L. growing in Egypt. Phytochemistry2004; 65:21132118.
  • 37
    Latvala A. Alkaloids of Galanthus elwesii. Phytochemistry1995; 39:12291240.
  • 38
    Wagner J, Huong L. Alkaloids from Hippeastrum Equestre Herb-5. Circular Dichroism Studies. Tetrahedron1996; 52:65916600.
  • 39
    Li SY, Chen C, Tan XH. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res2005; 67:1823.
  • 40
    Liu JG, Zhang LF. Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virology J2011; 8:483.
  • 41
    Szlávik L, Gyuris A, Minárovits J, Forgo P, Molnár J, Hohmann J. Alkaloids from Leucojum vernum and antiretroviral activity of Amaryllidaceae alkaloids. Planta Med2004; 70:871873.
  • 42
    CDC. Transmission of influenza A viruses between animals and people, the virus and its spread. 2005; October 17.
  • 43
    Dickneite; Gerhard (Marburg-Cappel, DE) Schorlemmer; Hans-UAAich (Weimar, DE) Sedlacek; Hans-Harald (Marburg, DE). Use of Lycorine as an immunosuppressor. 4699912 October 13, 1987.
  • 44
    Yui S, Mikami M, Kitahara M, Yamazaki M. The inhibitory effect of lycorine on tumor cell apoptosis induced by polymorphonuclear leukocyte-derived calprotectin. Immunopharmacology1998; 40:151162.
  • 45
    Ancuceanu RV, Istudor V. Pharmacologically active natural compounds for lung cancer. Altern Med Rev2004; 9:402419.
  • 46
    Van Goietsenoven G, Andolfi A. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells. J Nat Prod2010; 73:12231227.
  • 47
    Evidente A, Kireev AS, Jenkins AR, Romero AE, Kornienko A. Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design. Planta Med2009; 75:501507.